Pacific Biosciences
PACB
#8182
Rank
HK$2.80 B
Marketcap
HK$9.02
Share price
-2.95%
Change (1 day)
-8.78%
Change (1 year)

Earnings for Pacific Biosciences (PACB)

Earnings in 2026 (TTM): -HK$1 Billion

According to Pacific Biosciences 's latest financial reports the company's current earnings are HK$0.16 Billion. In 2025 the company made an earning of -HK$4.29 Billion a decrease over its 2024 earnings that were of -HK$2.43 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacific Biosciences from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1 Billion-76.71%
2025 -HK$4.29 Billion76.41%
2024 -HK$2.43 Billion-2.71%
2023 -HK$2.5 Billion1.24%
2022 -HK$2.47 Billion14.33%
2021 -HK$2.16 Billion-1034.84%
2020 HK$0.23 B-134.95%
2019 -HK$0.67 Billion-17.97%
2018 -HK$0.81 Billion11.25%
2017 -HK$0.73 Billion23.95%
2016 -HK$0.59 Billion134.65%
2015 -HK$0.25 Billion-52.09%
2014 -HK$0.52 Billion-16.56%
2013 -HK$0.63 Billion-16.08%
2012 -HK$0.75 Billion-13.78%
2011 -HK$0.86 Billion-21.76%
2010 -HK$1.1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
HK$58.22 B-5,908.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$89.82 B-9,061.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.10 B-1,007.87%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$3.72 B-471.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-HK$1.25 Billion 24.16%๐Ÿ‡บ๐Ÿ‡ธ USA